Skip to content
The Mumbai

Lupin Receives US FDA Tentative Approval For Apixaban Oral Suspension 1.25mg/mL

Lupin Receives US FDA Tentative Approval For Apixaban Oral Suspension 1.25mg/mL
Photo: Free Press Journal · view original

Mumbai: Lupin Limited on Monday, September 28, 2026, announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its New Drug Application (NDA) for Apixaban Oral Suspension 1.25mg/mL. Product Details Lupin’s Apixaban Oral Suspension 1.25mg/...

Sources and story details